Starting Dose of Trilipix for Normal Renal Function
For patients with normal renal function, start Trilipix at 135 mg once daily 1.
Dosing Algorithm Based on Indication
The FDA-approved starting dose varies by clinical indication:
For Primary Hyperlipidemia or Mixed Dyslipidemia
- Start at 135 mg once daily 1
- This is the standard dose for patients with normal renal function
- Can be taken without regard to meals 1
For Severe Hypertriglyceridemia
- Initial dose range: 45-135 mg once daily 1
- Individualize based on patient response
- Reassess lipid levels at 4-8 week intervals
- Maximum dose remains 135 mg once daily 1
When Co-administering with a Statin
- Use 135 mg once daily 1
- May be taken at the same time as the statin for convenience 1
- Critical caveat: Avoid co-administration with maximum-dose statins unless benefits clearly outweigh risks, as this has not been studied 1
Essential Pre-Treatment Requirements
Before initiating Trilipix at any dose 1:
- Verify renal function - Obtain baseline serum creatinine and eGFR
- Check baseline lipid panel - Confirm lipid abnormalities warrant treatment
- Assess liver function - Obtain hepatic transaminases
- Optimize lifestyle modifications - Ensure appropriate diet, exercise, and weight management are in place
Monitoring Schedule
After starting at 135 mg daily 1:
- Recheck renal function (creatinine and eGFR) within 3 months, then every 6 months
- Monitor lipid panel at 4-12 weeks after initiation, then every 3-12 months
Important Clinical Pitfalls
Do not use 135 mg if renal impairment is present - even mild-to-moderate renal impairment (eGFR 30-80 mL/min/1.73 m²) requires dose reduction to 45 mg daily 1. The ACC/AHA guidelines specifically state that fenofibrate should not exceed 54 mg/day when eGFR is 30-59 mL/min/1.73 m² 2.
Never combine with gemfibrozil and a statin - gemfibrozil significantly increases rhabdomyolysis risk and should not be initiated in patients on statin therapy 2.